Abcellera Biologics Inc.
Records under this name other than the patents Abcellera Biologics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 8 of 8 · Back to Abcellera Biologics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,400,281 | Methods for Determining Lymphocyte Receptor Chain Pairs Formerly held In force · High confidence | In force | High confidence | |
| US 12,460,318 | Methods for Determining Lymphocyte Receptor Chain Pairs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,371,166 | Methods for Determining Lymphocyte Receptor Chain Pairs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,725,052 | ANTI-PAR-2 Antibodies and Methods of Use Thereof Held by another company In force · High confidence | In force | High confidence | |
| US 12,384,841 | ANTI-PAR-2 Antibodies and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,240,902 | ANTI-TREM2 Antibodies and Methods of Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,447,541 | Anti-Coronavirus Antibodies and Methods of Use Lapsed on the fee record Ended Sep 20, 2026 · Low confidence | Lapsed on the fee record | Ended Sep 20, 2026 | Low confidence |
| US 11,370,828 | Anti-Coronavirus Antibodies and Methods of Use Lapsed on the fee record Ended Jun 28, 2026 · Medium confidence | Lapsed on the fee record | Ended Jun 28, 2026 | Medium confidence |